Page 4 - Gary Schoolnik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Visby Medical announced today that it picked up $25.5 million in government funding to develop an at-home flu/COVID-19 diagnostic.

Jack Remington, infectious-disease expert and clinician, dies at 90 The Stanford physician devised a test that saved babies’ lives by showing whether they needed immediate treatment for a parasitic disease called toxoplasmosis. Apr 27 2021 Jack Remington Jack Remington, MD, professor emeritus of infectious diseases at Stanford Medicine, died April 8 in Menlo Park, California, of complications from an injury he sustained in a fall. He was 90. An extreme-sports enthusiast with a penchant for mountain climbing, which over the years exacted a physical toll on his body, Remington was...

What the Coronavirus Variants Mean for Testing Most tests should be able to detect the variants of concern, but test developers and health officials must remain vigilant, scientists say. A man receives a nasal swab at a mobile Covid-19 testing site in  Queens, N.Y., in early April.Credit...Shannon Stapleton/Reuters By Emily Anthes April 14, 2021, 3:00 p.m. ET In January 2020, just weeks after the first Covid-19 cases emerged in China, the full genome of the new coronavirus was published online. Using this genomic sequence, scientists scrambled to design a large assortment of diagnostic tests...

As new and more contagious variants of the COVID-19 virus emerge in California at a troubling rate, testing for the pathogen has plummeted, challenging the state’s effort to trace spread, discover outbreaks or detect whether the variants are eluding vaccines. Rates of testing have fallen by more than 60% since January’s peak, according to the most recent data by the California Department of Public Health. Statewide, a total of 186,112 tests were reported on March 31, down from 477,718 on Jan. 4. The precipitous decline is reflected in Bay Area data, as well, falling about 40% in San...

Share this article Share this article SAN JOSE, Calif., Feb. 10, 2021 /PRNewswire/ -- Visby Medical™ announced today the US Food and Drug Administration (FDA) authorized Visby's rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA's emergency use authorization granted earlier this year, Visby Medical's rapid PCR COVID-19 test may now be used by any organization with a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver. Visby Medical Test - Now Authorized for CLIA-Waived Settings It is imperative that the best tools are available to fight infec...